GLP-1 receptor agonist
Dulaglutide dose
Answer
FDA label for Trulicity: Recommended starting dosage is 0.75 mg injected subcutaneously once weekly. Trials with posted results tested 4 doses, most often 1.5 mg, 0.75 mg, 4.5 mg.
Not dosing advice.
FDA LABEL
What the approved labels state
Trulicity BLA125469 · label of 2026-06-16 Regulator
Recommended starting dosage is 0.75 mg injected subcutaneously once weekly.
Maximum recommended dosage is 4.5 mg injected subcutaneously once weekly.
IN TRIALS
Doses tested in 61 trials with posted results
| Dose in the arm title | Trials | People on it | Phases |
|---|---|---|---|
| 1.5 mg | 15 | 9,704 | 2/3/4 |
| 0.75 mg | 11 | 2,059 | 3/4 |
| 4.5 mg | 3 | 833 | 2/3/4 |
| 3 mg | 2 | 695 | 2/3 |
Trial register Read from the titles of arms that received Dulaglutide (n ≥ 20). An arm naming several doses counts under each; a schedule or escalation is on the trial record. All trials.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.